CSIMarket
 
Abcellera Biologics Inc   (NASDAQ: ABCL)
Other Ticker:  
 
 

Abcellera Biologics Inc Balance Sheets Quarterly

ABCL


Select the Financial Report:   Period:




ABCL Balance Sheets
(Quarterly, GAAP in millions $)

(Sep 30 2023)
Q3
(Jun 30 2023)
Q2
(Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
ASSETS
Cash & cash equivalent 172.42 179.75 193.02 386.54 371.97
Cash, Cash Eqvivalents Other - - - - -
Available-for-sale Securities, Debt Securities MA 613.42 615.95 603.48 499.95 496.23
Cash & Short-term Investments 785.84 795.69 796.50 886.49 868.21
Accounts receivable - - - - -
Unbilled Receivables, Current RE - - - - -
Notes Receivable, Current - - - - -
Cash Cash Equivalents And Marketable Securities 785.84 795.69 796.50 886.49 868.21
Accounts And Accrued Receivable Current 37.45 45.68 20.00 38.59 105.96
Inventories - - - - -
Other Current Assets 133.68 135.04 144.16 139.01 177.46
Total Current Assets 919.52 930.74 940.65 1,025.49 1,045.67
Equipment/Property/Plant Net 277.21 259.64 233.19 217.26 200.60
Goodwill net 47.81 47.81 47.81 47.81 47.81
Intangible Assets 124.08 126.75 128.85 131.50 142.55
Long-term investments 62.89 58.79 57.58 72.52 66.72
Accounts Receivable, Net, Noncurrent - - - - -
Financial Instruments - - - - -
Tax Assets, Noncurrent - - - - -
Other Assets, Noncurrent 83.00 117.00 92.00 48.00 52.00
Deferred, Prepaid and Other Assets, Noncurrent - - - - -
Discontinued operations, Noncurrent - - - - -
Total Assets 1,512.19 1,537.17 1,497.92 1,540.91 1,552.41
LIABILITIES
Accounts Payable and Other Accrued Liabilities, Current - - - - -
Accrued Liabilities, Current 35.71 52.40 31.81 33.15 25.87
Financial Instruments - - - - -
Shortterm Debt - - - - -
Other Liabilities, Current 20.60 11.64 14.90 40.96 24.64
Accrued Income Taxes, Current TA - - - - 23.02
Deferred Liability and Revenue - - - - -
Business Combination, Contingent Consideration, Liability, Current BU 53.93 54.87 42.88 44.21 32.53
Contract With Customer Liability Current 17.51 8.54 11.81 21.61 6.82
Total Current Liabilities 110.24 118.91 89.59 118.32 106.05
Long-term debt - - - - -
Capital Lease and Other - - - - -
Long-term Debt Convertible - - - - -
Total Long-term Debt - - - - -
Financial Instruments, Insurance, Noncurrent - - - - -
Employee Benefit Plans, Noncurrent - - - - -
Deferred credits, Noncurrent - - - - -
Accrued Income Taxes, Noncurrent - - - - -
Discontinued Operation, Liabilities, Noncurrent - - - - -
Other liabilities, Noncurrent 219.18 223.43 199.83 189.31 196.19
Operating Lease Liability Noncurrent 75.19 78.08 77.27 76.68 71.59
Deferred Revenue And Grant Funding Noncurrent - - - - 62.20
Deferred Income Tax Liabilities Net 33.18 33.18 33.43 33.18 34.14
Total Liabilities 329.42 342.34 289.42 307.63 302.24
SHAREHOLDER'S EQUITY
Common Stock Value 747.91 744.76 742.82 734.37 730.43
Additional Paid In Capital Common Stock 109.38 96.42 81.63 74.12 64.38
Retained Earnings / Accumulated Deficit 326.94 355.55 386.08 426.19 456.08
Other Equity -1.46 -1.90 -2.02 -1.39 -0.72
Noncontrolling interests & other - - - - -
Total Stockholder's Equity 1,182.78 1,194.83 1,208.50 1,233.28 1,250.17
Liabilities & Stockholder's Equity 1,512.19 1,537.17 1,497.92 1,540.91 1,552.41




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com